Compare SPRY & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRY | HEPS |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | Turkey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 948.0M |
| IPO Year | 2020 | 2021 |
| Metric | SPRY | HEPS |
|---|---|---|
| Price | $9.11 | $2.86 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $35.00 | $3.07 |
| AVG Volume (30 Days) | ★ 889.4K | 236.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 114.04 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $89,149,000.00 | N/A |
| Revenue This Year | N/A | $29.01 |
| Revenue Next Year | $119.97 | $21.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 297063.34 | N/A |
| 52 Week Low | $6.66 | $2.15 |
| 52 Week High | $18.63 | $3.46 |
| Indicator | SPRY | HEPS |
|---|---|---|
| Relative Strength Index (RSI) | 42.09 | 60.32 |
| Support Level | $8.61 | $2.67 |
| Resistance Level | $10.44 | $2.92 |
| Average True Range (ATR) | 0.44 | 0.11 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 40.31 | 79.79 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.